GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Series GSE124192 Query DataSets for GSE124192
Status Public on Jun 01, 2021
Title Transcriptional profiling of murine germinal center (GC) B cells from GC-specific conditional Crebbp and Ep300 knock-out mice
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Inactivating mutations of the CREBBP acetyltransferase and, at lower frequencies, its paralogue EP300 are among the most common genetic alterations in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL), the two most frequent B cell malignancies. Here we uncover unexpected distinct functions for CREBBP and EP300 in the germinal center (GC), i.e. the target structure for most human B cell lymphomas. We show that these proteins modulate non-overlapping transcriptional programs that are preferentially enriched in biological functions associated with the separate anatomic compartments of the GC. Consistently, deletion of CREBBP or EP300 have opposing effects on GC formation in vivo. Nonetheless, these proteins partially compensate for each other to maintain a minimal threshold of acetyltransferase activity and guarantee homeostatic control of the GC, which is completely abrogated by their combined loss. This synthetic lethal interaction is retained in DLBCL cells, identifying an Achille’s heel in CREBBP-mutant lymphomas that could be pharmacologically targeted by using a novel, selective small molecule inhibitor of the CREBBP/EP300 bromodomain. These data shed light on the unique roles of CREBBP and EP300 in the physiology and pathology of GC B cells, and provide a proof-of-principle for the development and testing of EP300 inhibition as a therapeutic strategy in these diseases.
Overall design Animals were immunized by intraperitoneal injection of sheep-red-blood-cells to induce T-cell dependent responses, and GC B cells (B220+CD95+PNA+) were sorted 12 days post immunization to extract total RNA for next generation sequencing analysis, as described in detail in the associated manuscript.
Contributor(s) Pasqualucci L, Holmes AB
Citation(s) 31519498
NIH grant(s)
Grant ID Grant title Affiliation Name
R01 CA172492 Role of KMT2D Gene Inactivation in B cell Non Hodgkin Lymphoma Trustees of Columbia University in the City of New York Laura Pasqualucci
P50 CA192937 MSK SPORE in Lymphoma Sloan Kettering Institute for Cancer Research ANAS YOUNES
P50 CA192937 MSK SPORE in Lymphoma Sloan Kettering Institute for Cancer Research ANDREW D. ZELENETZ
Submission date Dec 20, 2018
Last update date Jun 01, 2021
Contact name Laura Pasqualucci
Organization name Columbia University
Department Institute for Cancer Genetics
Street address 1130 St Nicholas Avenue
City New York
State/province NY
ZIP/Postal code 10032
Country USA
Platforms (1)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
Samples (11)
GSM3523680 WT_41
GSM3523681 WT_4
GSM3523682 WT_7
BioProject PRJNA510973
SRA SRP174041

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE124192_counts_deseq2_normalized.txt.gz 1.6 Mb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap